Acuitas Therapeutics, headquartered in Vancouver, BC, advances pharmaceutical innovation through specialized nanotechnology research and development. The company focuses on enabling new medicines by leveraging cutting-edge nanotech solutions, positioning itself as a key contributor in the biotech sector.

‌